MAIA Biotechnology, Inc. (MAIA) Press Releases https://ir.maiabiotech.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/maiabiotech/files/theme/images/logo-sm.png MAIA Biotechnology, Inc. Logo Equisolve Investor Relations Suite <![CDATA[MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer]]> https://ir.maiabiotech.com/news-events/press-releases/detail/173/maia-biotechnology-activates-first-u-s-site-for-ongoing Thu, 16 Apr 26 09:20:00 -0400 https://ir.maiabiotech.com/news-events/press-releases/detail/173/maia-biotechnology-activates-first-u-s-site-for-ongoing <![CDATA[MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy]]> https://ir.maiabiotech.com/news-events/press-releases/detail/172/maia-biotechnology-expects-recent-33-million-capital-raise Wed, 08 Apr 26 09:00:00 -0400 https://ir.maiabiotech.com/news-events/press-releases/detail/172/maia-biotechnology-expects-recent-33-million-capital-raise <![CDATA[MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer]]> https://ir.maiabiotech.com/news-events/press-releases/detail/171/maia-biotechnology-reports-overall-survival-exceeding-two Tue, 31 Mar 26 09:15:00 -0400 https://ir.maiabiotech.com/news-events/press-releases/detail/171/maia-biotechnology-reports-overall-survival-exceeding-two <![CDATA[MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock]]> https://ir.maiabiotech.com/news-events/press-releases/detail/170/maia-biotechnology-announces-closing-of-30-million Wed, 04 Mar 26 16:00:00 -0500 https://ir.maiabiotech.com/news-events/press-releases/detail/170/maia-biotechnology-announces-closing-of-30-million <![CDATA[MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock]]> https://ir.maiabiotech.com/news-events/press-releases/detail/169/maia-biotechnology-announces-pricing-of-30-million Mon, 02 Mar 26 22:45:00 -0500 https://ir.maiabiotech.com/news-events/press-releases/detail/169/maia-biotechnology-announces-pricing-of-30-million <![CDATA[MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants]]> https://ir.maiabiotech.com/news-events/press-releases/detail/168/maia-biotechnology-announces-proposed-underwritten-public Mon, 02 Mar 26 17:00:00 -0500 https://ir.maiabiotech.com/news-events/press-releases/detail/168/maia-biotechnology-announces-proposed-underwritten-public <![CDATA[MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market]]> https://ir.maiabiotech.com/news-events/press-releases/detail/167/maia-biotechnologys-phase-3-momentumdemonstrates Tue, 24 Feb 26 08:45:00 -0500 https://ir.maiabiotech.com/news-events/press-releases/detail/167/maia-biotechnologys-phase-3-momentumdemonstrates <![CDATA[MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum]]> https://ir.maiabiotech.com/news-events/press-releases/detail/166/maia-biotechnology-advances-ateganosine-cancer-treatment Tue, 20 Jan 26 10:15:00 -0500 https://ir.maiabiotech.com/news-events/press-releases/detail/166/maia-biotechnology-advances-ateganosine-cancer-treatment <![CDATA[MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings]]> https://ir.maiabiotech.com/news-events/press-releases/detail/165/maia-biotechnology-board-members-continue-to-participate-in Wed, 24 Dec 25 08:01:00 -0500 https://ir.maiabiotech.com/news-events/press-releases/detail/165/maia-biotechnology-board-members-continue-to-participate-in <![CDATA[MAIA Biotechnology Announces $1.51 Million Private Placement]]> https://ir.maiabiotech.com/news-events/press-releases/detail/164/maia-biotechnology-announces-1-51-million-private-placement Tue, 16 Dec 25 16:15:00 -0500 https://ir.maiabiotech.com/news-events/press-releases/detail/164/maia-biotechnology-announces-1-51-million-private-placement